Reducing the Burden of Clostridium difficile Infection (CDI): Spotlight on Populations at Risk

VOORHEES, N.J., June 16, 2011 /PRNewswire/ -- Hypervirulent strains and increased frequency of Clostridium difficile infection (CDI) have resulted in more severe disease and increased costs to the healthcare system in recent years. Fortunately, innovative therapies for the treatment of CDI are emerging.  In order to improve patient outcomes, healthcare professionals must be aware of special considerations for at-risk populations, as well as the changing epidemiology, emerging novel treatment strategies, and best practices for prevention of CDI.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture for physicians and nurses. This activity, which is derived from a live symposium presented on May 8, 2011, in Chicago, Illinois, is supported by an educational grant from Optimer Pharmaceuticals.

Jorge P. Parada, MD, MPH, FACP, FIDSA, David G. Binion, MD, and Ciaran P. Kelly, MD, serve as faculty for this online virtual lecture.

Healthcare professionals can visit www.rmei.com/CDI400VL to participate today.

RMEI is a medical education company that specializes in independent, continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, webinars, grand rounds, print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.

SOURCE Robert Michael Educational Institute LLC